Back
  1. Home
  2. Profile of Ange Ilangala Booka (ULiège)
Profil

Ilangala Booka Ange

Faculté des Sciences > Doct. scienc. (biol. organ. écol.)

ORCID
0000-0002-2307-1931
Main Referenced Co-authors
Fillet, Marianne  (2)
Lechanteur, Anna  (2)
Piel, Géraldine  (2)
Akombaetwa, Nakamwi (1)
Akopova, Tatiana A. (1)
Main Referenced Keywords
active targeting (1); anticancer peptide, liposomes, LC-UV, quality control (1); Anticancer peptides, liposomes, encapsulation efficiency (1); bioavailability (1); Biocompatibility, hemocompatibility (1);
Main Referenced Unit & Research Centers
CIRM - Centre Interdisciplinaire de Recherche sur le Médicament - ULiège [BE] (1)
Main Referenced Disciplines
Pharmacy, pharmacology & toxicology (13)
Oncology (1)

Publications (total 14)

The most downloaded
431 downloads
Ilangala Booka, A., Lechanteur, A., Fillet, M., & Piel, G. (2021). Therapeutic peptides for chemotherapy: trends and challenges for advanced delivery systems. European Journal of Pharmaceutics and Biopharmaceutics. doi:10.1016/j.ejpb.2021.07.010 https://hdl.handle.net/2268/263149

The most cited

17 citations (Scopus®)

Ilangala Booka, A., Lechanteur, A., Fillet, M., & Piel, G. (2021). Therapeutic peptides for chemotherapy: trends and challenges for advanced delivery systems. European Journal of Pharmaceutics and Biopharmaceutics. doi:10.1016/j.ejpb.2021.07.010 https://hdl.handle.net/2268/263149

Ilangala Booka, A. (2023). Exploration of pharmaceutical nanocarriers as a drug delivery strategy for bioavailability enhancement of challenging drugs across biological barriers [Doctoral thesis, ULg - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/309344

Pierrot Mwamba Tshilumba, J.-B. K. N., & Ilangala Booka, A. (2023). Detection of Substandard and Falsified Antibiotics Sold in the Democratic Republic of the Congo Using Validated HPLC and UV-Visible Spectrophotometric Methods. American Journal of Tropical Medicine and Hygiene. doi:10.4269/ajtmh.23-0045
Peer reviewed

Ilangala Booka, A. (27 April 2023). In-vitro evaluation of biocompatibility of nanomedicines intented for IV route: focus on cytotoxicity and hemocompatibility tests [Paper presentation]. Première journée scientifique du centre interdisciplinaire des sciences pharmaceutiques, Université de Kinshasa, Kinshasa, Congo - Kinshasa.

Akombaetwa, N., Ilangala Booka, A., Lorraine Thom, Patrick B. Memvanga, Bwalya Angel Witika, & Aristote B. Buya. (2023). Current Advances in Lipid Nanosystems Intended for Topical and Transdermal Drug Delivery Applications. Pharmaceutics. doi:10.3390/pharmaceutics15020656
Peer Reviewed verified by ORBi

Ilangala Booka, A. (2022). Addressing the current medical needs for better management of complex diseases: how advanced drug delivery technologies are impacting modern healthcare [Paper presentation]. Webinar organized by BEBUC Scholarship (Bourse d'excellence Bringmann aux Université Congolaises), Kinshasa, Congo - Kinshasa.

Sherstneva, A. A., Demina, T. S., Monteiro, A., Akopova, T. A., Grandfils, C., & Ilangala Booka, A. (24 March 2022). Biodegradable Microparticles for Regenerative Medicine: A State of the Art and Trends to Clinical Application. Polymers, 14 (7), 1314. doi:10.3390/polym14071314
Peer Reviewed verified by ORBi

Ilangala Booka, A., Lechanteur, A., Fillet, M., & Piel, G. (2021). Therapeutic peptides for chemotherapy: trends and challenges for advanced delivery systems. European Journal of Pharmaceutics and Biopharmaceutics. doi:10.1016/j.ejpb.2021.07.010
Peer Reviewed verified by ORBi

Ilangala Booka, A. (06 April 2021). Evaluation of the physicochemical characteristics of pH sensitive liposome formulations for effective endosomal escape and cytosolic delivery [Paper presentation]. Early Career Scientist Meeting 2021/Controlled Release Society BeNeLux & France Local Chapter.

Ilangala Booka, A. (04 March 2021). A physicochemical test to assess the performance of pH sensitive liposomes for effective endosomal escape and cytosolic delivery [Paper presentation]. CRS Local Virtual Chapters Meeting Germany and BeNeLux & France.

Ilangala Booka, A. (2021). Nanotechnology based systems for the delivery of anticancer therapeutics [Paper presentation]. Jounée scientifique "Nanotechnology Day" - Université de Kinshasa - RDC, Kinshasa, Congo - Kinshasa.

Ilangala Booka, A. (2020). LC-UV as tool for nanovectorized anticancer peptide quality control: evaluation of encapsulation efficiency [Poster presentation]. Séminaire des chercheurs Télévie 2020 - UCL - Belgique, Brussels, Belgium.

Ilangala Booka, A. (17 December 2019). LC-UV as tool for nanovectorized anticancer peptide quality control: assessment of peptide adsorption to solid materials used for the determination of encapsulation efficiency [Poster presentation]. Meeting of the Belgian-Dutch Biopharmaceutical Society - UGent - Belgique, Ghent, Belgium.
Peer reviewed

Ilangala Booka, A., COBRAIVILLE, G., EVRARD, A., Sonveaux, Lechanteur, A., Piel, G., & Fillet, M. (11 December 2019). LC-UV as tool for nanovectorized anticancer peptide quality control: evaluation of encapsulation efficiency [Poster presentation]. 2nd Edition of CIRM day, Liege, Belgium.

Ilangala Booka, A., Ciza Hamuli, P., Prakash B., R., & Rajanrajan. (12 January 2016). Design, Development and Optimization of Topotecan Hydrochloride Solid Lipid Nanoparticles for Oral Chemotherapy. Journal of Nanomedicine Research, 3 (1/00044), 1-12. doi:10.15406/jnmr.2016.03.00044
Peer reviewed

Contact ORBi